"
Team:UT-Dallas
From 2014.igem.org
(Difference between revisions)
| (10 intermediate revisions not shown) | |||
| Line 9: | Line 9: | ||
<script src="https://2014.igem.org/Team:UT-Dallas/dropit.js?action=raw&ctype=text/javascript"></script> | <script src="https://2014.igem.org/Team:UT-Dallas/dropit.js?action=raw&ctype=text/javascript"></script> | ||
<div id="content_body"> | <div id="content_body"> | ||
| - | <section id="titlechart"> | + | <section id="titlechart"></html>{{Header_menu}}<html><div id="project_desc"><br><h2>PROJECT</H2><p> |
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
Treating infectious diseases of the gastrointestinal (GI) tract with antibiotics disrupts a patient's gut microbiota and can increase the prevalence of antibiotic resistant strains. The increasing population of multi-drug resistant bacterial strains, both within and outside of health centers, is a growing health concern that is becoming progressively difficult to treat. Additionally, it is a well-recognized fact within the global health community that traditional antibiotics do not represent a sustainable method of treatment for bacterial infections. There is a clear drive towards minimally invasive, prophylactic therapies for such ailments, but is a demand that so far, has not been adequately met. Our project will aim at replacing broad and narrow spectrum antibiotics with “precision therapies” that have etiology targeting capacity at the species level as well as contain minimal cross-talk among healthy tissues, organs, and symbiotic organisms. | Treating infectious diseases of the gastrointestinal (GI) tract with antibiotics disrupts a patient's gut microbiota and can increase the prevalence of antibiotic resistant strains. The increasing population of multi-drug resistant bacterial strains, both within and outside of health centers, is a growing health concern that is becoming progressively difficult to treat. Additionally, it is a well-recognized fact within the global health community that traditional antibiotics do not represent a sustainable method of treatment for bacterial infections. There is a clear drive towards minimally invasive, prophylactic therapies for such ailments, but is a demand that so far, has not been adequately met. Our project will aim at replacing broad and narrow spectrum antibiotics with “precision therapies” that have etiology targeting capacity at the species level as well as contain minimal cross-talk among healthy tissues, organs, and symbiotic organisms. | ||
</p><br><br> | </p><br><br> | ||
| Line 52: | Line 18: | ||
<div id="parallax1" class="spacer s2" style="background-image: url(https://static.igem.org/mediawiki/2014/1/19/UTD_Lab.jpg);"></div> | <div id="parallax1" class="spacer s2" style="background-image: url(https://static.igem.org/mediawiki/2014/1/19/UTD_Lab.jpg);"></div> | ||
<div class="spacer s1"> | <div class="spacer s1"> | ||
| - | <div id="team_box"> | + | <div id="team_box"><a name='team'></a> |
<br><h2>THE TEAM</H2><br><p> | <br><h2>THE TEAM</H2><br><p> | ||
<table id="team_table"> | <table id="team_table"> | ||
<tr> | <tr> | ||
<td> | <td> | ||
| - | <img src="https://static.igem.org/mediawiki/2014/1/13/Tyler-profile-image.png" height="400px" width="400px" class="tooltip" title="<h2 class='info_h2'>Tyler</h2> | + | <img src="https://static.igem.org/mediawiki/2014/1/13/Tyler-profile-image.png" height="400px" width="400px" class="tooltip" title="<h2 class='info_h2'>Tyler</h2>Hey there! My name is Tyler. I graduated in 2013 as a biochemistry major at the University of Texas at Dallas. <p>I participated in iGEM in 2011 as a student and this year served as the UT Dallas iGEM team advisor. |
| + | |||
| + | I think iGEM provides an excellent opportunity to get students involved in biomedical research. | ||
| + | |||
| + | In the future, I hope to utilize synthetic biology to tackle problems in the medical field."> | ||
</td> | </td> | ||
<td id="pad_td"> | <td id="pad_td"> | ||
| Line 71: | Line 41: | ||
<tr> | <tr> | ||
<td> | <td> | ||
| - | <img src="https://static.igem.org/mediawiki/2014/8/8b/Tra-profile-image.png" height="400px" width="400px" class="tooltip" title="<h2 class='info_h2'>Tra</h2>Tra is biology major but she is still deciding between Molecular Cell Biology and Mathematics. Nevertheless, she loves both. Since she is good at math, she does the biological system modelling for our project, despite having any prior programming experience. She learned gro and MatLab just for iGEM. Aside from wet lab work, she also helps with building the wiki. Tra loves languages. She is learning Japanese, Russian, | + | <img src="https://static.igem.org/mediawiki/2014/8/8b/Tra-profile-image.png" height="400px" width="400px" class="tooltip" title="<h2 class='info_h2'>Tra Ngo</h2>Tra is biology major but she is still deciding between Molecular Cell Biology and Mathematics. Nevertheless, she loves both. Since she is good at math, she does the biological system modelling for our project, despite having any prior programming experience. She learned gro and MatLab just for iGEM. Aside from wet lab work, she also helps with building the wiki. Tra loves languages. She is learning Japanese, Russian, html, and css. When there is dead time in the lab you will find her occasionally engaging in conversations on the topic of Math as a language with our labs post-doc. In between reactions, if she is not utilizing time by cleaning the lab bench, Tra would do calligraphy on the white board. Tra is an iGEM late-comer but she soon became an essential part of the team. |
| - | <br><br>The song ‘Tra's Brief Life as a Spider’ | + | <br><br>The song ‘Tra's Brief Life as a Spider’ reveals her life prior to iGEM. She was briefly reincarnated as a spider, then later, as a Wild Horse on the planet of nearly, where wild horses hold the majority in the senate. She likes pudding, but only without raisins. |
| - | <br><br>When not doing iGEM wet lab and dry lab work, Tra enjoys swing dancing, sacrificing bishops (in chess club), setting ants on fire with isopropanol, and slashing people with sabre (in fencing club). | + | <br><br>When not doing iGEM wet lab and dry lab work, Tra enjoys swing dancing, sacrificing bishops (in chess club), setting ants on fire with isopropanol, and slashing people with sabre (in fencing club). She occasionally bring borscht, mooncakes, and cashew butter to the lab. |
<br><br>Tra is at the same time engaging in a math research. She is looking to further the application of math in the study of biology."> | <br><br>Tra is at the same time engaging in a math research. She is looking to further the application of math in the study of biology."> | ||
</td> | </td> | ||
| Line 87: | Line 57: | ||
</div> | </div> | ||
</div> | </div> | ||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
<script src="https://2014.igem.org/Team:UT-Dallas/general.js?action=raw&ctype=text/javascript"></script> | <script src="https://2014.igem.org/Team:UT-Dallas/general.js?action=raw&ctype=text/javascript"></script> | ||
</section> | </section> | ||
</div> | </div> | ||
</html> | </html> | ||
Latest revision as of 22:25, 29 December 2014
PROJECT
Treating infectious diseases of the gastrointestinal (GI) tract with antibiotics disrupts a patient's gut microbiota and can increase the prevalence of antibiotic resistant strains. The increasing population of multi-drug resistant bacterial strains, both within and outside of health centers, is a growing health concern that is becoming progressively difficult to treat. Additionally, it is a well-recognized fact within the global health community that traditional antibiotics do not represent a sustainable method of treatment for bacterial infections. There is a clear drive towards minimally invasive, prophylactic therapies for such ailments, but is a demand that so far, has not been adequately met. Our project will aim at replacing broad and narrow spectrum antibiotics with “precision therapies” that have etiology targeting capacity at the species level as well as contain minimal cross-talk among healthy tissues, organs, and symbiotic organisms.
